Pascale Leroueil, Vice President of Healthcare at the William Davidson Institute at the University of Michigan discusses a recent study where she and co-authors present a method for estimating the impact of vaccine technologies on vaccination coverage rates. They designed the method to help decision-makers better assess the most value for their money, with the goal of improving vaccine coverage for vulnerable communities. She talks about if the methodology can be applied to other types of vaccine technologies and what the pandemic revealed in terms of vaccine coverage that this research might address.

Pascale R. Leroueil is the vice president of the Healthcare sector at the William Davidson Institute at the University of Michigan (WDI). Her research is focused on applying business practices to sustainably address human health needs in emerging markets. She has worked with both public and private health systems to increase their efficiency of care. She also holds an adjunct appointment at the University of Michigan’s Stephen M. Ross School of Business. Before joining WDI, she worked in vaccine development at the University of Michigan’s Medical School. Leroueil earned her PhD in physical chemistry from the University of Michigan, and her MBA from U-M’s Ross School of Business.

Liked it? Take a second to support healthprofessionalradio on Patreon!